After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
MXCT belongs to the Healthcare sector of the NASDAQ while operating in the Medical Devices industry. The current market capitalization of MaxCyte Inc is $142.85M. A total of 0.69 million shares were traded on the day, compared to an average of 838.51K shares.
In the most recent transaction, Hemrajani Rekha sold 10,684 shares of MXCT for 2.09 per share on Jun 25 ’25. After the transaction, the Director now owns 39,893 company shares. In a previous transaction on Aug 13 ’25, Swirsky Douglas J bought 50,000 shares at 1.29 per share. MXCT shares that CHIEF FINANCIAL OFFICER owns now total 161,811.
Among the insiders who bought shares, Masoud Maher acquired of 75,000 shares on Aug 13 ’25 at a per-share price of $1.37. This resulted in the President and CEO holding 175,000 shares of MXCT after the transaction. In another insider transaction, Erck Stanley C bought 100,000 shares at $1.37 per share on Aug 13 ’25. Company shares held by the Director now total 398,328.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, MXCT has a high of $5.20 and a low of $1.26.
As of this writing, MXCT has an earnings estimate of -$0.11 per share for the current quarter. EPS was calculated based on a consensus of 4.0 estimates, with a high estimate of -$0.1 per share and a lower estimate of -$0.12. The company reported an EPS of -$0.11 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. MXCT’s latest balance sheet shows that the firm has $255.04M in Cash & Short Term Investments as of fiscal 2021. There were $5.68M in debt and $15.62M in liabilities at the time. Its Book Value Per Share was $1.79, while its Total Shareholder’s Equity was $262.90M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MXCT is Buy with a score of 4.14.
